Trial
NCT04650204
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Intractable Epilepsy
Intervention
Anticonvulsant Agent
Why stopped
The funding sponsor, EISAI, sold the US rights to the medication and can no longer provide it to patients for the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-22